BU
CC icon

BBVA USA’s Chemours CC Stock Holding History

BBVA USA’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$11K Hold
379
– – ﹤0.01% 818
2021
Q2 		$13K Buy
+379
New +$12.6K ﹤0.01% 834

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

BBVA USA's CC Position: Q3 2021 in Review

BBVA USA held its Chemours (CC) position steady in Q3 2021 at 379 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #818.

BBVA USA first reported a position in CC in Q2 2021 and has held it in 2 quarters since. The position peaked at $13K in Q2 2021. 460 funds tracked by Wall St. Rank hold CC as of Q3 2021.

  • BBVA USA held 379 shares of Chemours worth $11K as of Q3 2021.
  • BBVA USA left its Chemours share count unchanged in Q3 2021.
  • Chemours made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #818 holding.
  • BBVA USA first reported a position in Chemours in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Chemours position peaked at $13K in Q2 2021.
  • 460 funds tracked by Wall St. Rank held Chemours as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.